We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Hormone therapy · Topical & vaginal
Topical and vaginal estradiol — EstroGel, Divigel, Elestrin, Estrace Cream, Premarin Vaginal Cream
Estrogen creams cover two distinct uses: systemic transdermal estradiol creams and gels for whole-body menopause symptoms, and low-dose vaginal estrogen creams for genitourinary symptoms (GSM) like vaginal dryness and painful sex.
Medically reviewed by Dr. Ana Lisa Carr, MD, MBA · Last reviewed 2026-05-10
"Estrogen cream" refers to two very different categories of medication. Confusing them is one of the most common questions Kindr providers answer.
Systemic transdermal estradiol (EstroGel, Divigel, Elestrin, Estrasorb) is applied to the arm or thigh once daily and absorbs through the skin to deliver bloodstream-level estradiol — equivalent to a patch, used to treat full-body menopause symptoms like hot flashes and night sweats.
Low-dose vaginal estrogen cream (Estrace Cream, Premarin Vaginal Cream) is applied inside the vagina at very low doses to treat genitourinary syndrome of menopause (GSM) — vaginal dryness, burning, urinary urgency, painful sex. Systemic absorption is minimal, and NAMS has concluded that for GSM the boxed warning likely overstates the actual risks of this category.
Systemic creams/gels: estradiol crosses the skin, enters the bloodstream, and restores ovarian-level estradiol — reducing hot flashes, night sweats, and protecting bone.
Vaginal creams: estradiol restores the vaginal epithelium, normalizes pH, rebuilds tissue elasticity, and improves urinary symptoms — with serum estradiol levels typically remaining in the postmenopausal range.
Systemic estrogen creams and gels (EstroGel, Divigel) are applied to the arm or thigh once daily and work like a patch — full-body menopause treatment. Vaginal estrogen creams are applied internally at very low doses for vaginal and urinary symptoms only, with minimal systemic absorption.
NAMS, ACOG, and ASCO have all concluded that low-dose vaginal estrogen is appropriate for many breast cancer survivors with severe GSM after shared decision-making with their oncologist — particularly when non-hormonal options have failed.
Most patients notice improvement in dryness and comfort within 2–4 weeks. Full restoration of vaginal tissue takes 8–12 weeks of consistent use.
For most patients on standard low-dose vaginal estrogen, NAMS does not require a progestogen — systemic absorption is too low to stimulate the endometrium. Higher doses or longer-term use may warrant endometrial monitoring.
Yes — Kindr is a licensed telehealth practice in all 50 states. After a brief intake and 24-hour physician review, an FDA-approved estrogen cream (systemic or vaginal) is sent to your pharmacy.
Medically reviewed by Dr. Ana Lisa Carr, MD, MBA
Board-Certified Family Medicine Physician · Lead Provider / Medical Reviewer
NPI 1689841744 · Last reviewed: May 10, 2026
Hormone therapy
Micronized Progesterone →Hormone therapy
Testosterone (low-dose, female-physiologic) →Hormone therapy
Semaglutide →GLP-1 weight care
This page is educational and is not a substitute for a clinical evaluation. Whether any medication is appropriate for you depends on your full medical history. Kindr providers make individualized prescribing decisions during a clinical visit.